The Food and Drug Administration approved Philadelphia-based Lannett's metaxalone tablets.
Here are three things to know.
1. The drug is a muscle relaxant intended to treat patients with acute, painful musculoskeletal conditions.
2. Metaxalone tablets are a generic version of King Pharmaceuticals' drug Skelaxin.
3. Lannett plans to launch the drug this quarter.
More articles on supply chain:
Court orders contracted pilots for Amazon, DHL to return to work after strike
Medisafe and TimerCap launch Bluetooth-enabled pill bottle to track medication adherence
Demand for durable manufactured goods rose 4.8% in October — largest jump in a year